| Type | Indexed | Publication . Mgi Jnum | J:332692 |
| Publication . Citation | Wang Y, et al. (2020) OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation. Br J Pharmacol 177(13):3060-3074 |